Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Braz J Med Biol Res ; 27(8): 1725-31, 1994 Aug.
Article in English | MEDLINE | ID: mdl-7749364

ABSTRACT

A human B2 bradykinin receptor cDNA was cloned from the lung fibroblast cell line, CCD-Lu. This clone was utilized to isolate a genomic clone of a mouse B2 bradykinin receptor. Both clones encode a protein that has the predicted characteristics of a seven transmembrane domain G-protein-coupled receptor. The DNA sequence of these two clones is 84% identical in the putative coding region. The clones have been heterologously expressed in a mammalian cell line lacking endogenous bradykinin receptors, COS-7, and a comparative analysis of their pharmacology was done. Both clones exhibit properties characteristic of the B2 bradykinin receptor, binding bradykinin with high affinity (KD = 0.1-0.2 nM) and binding des-Arg9 bradykinin with a very low affinity (IC50 > 5 microM). Interestingly, the mouse B2 bradykinin receptor has a 60-80 fold higher affinity than the human B2 bradykinin receptor for the peptide antagonists D-Arg0[Hyp3,Thi5,8,D-Phe7]bradykinin and D-Arg0[Hyp3,D-Phe7]bradykinin.


Subject(s)
Receptors, Bradykinin/genetics , Amino Acid Sequence , Animals , Binding, Competitive , CHO Cells , Cell Line , Cloning, Molecular , Cricetinae , DNA, Complementary , Humans , Mice , Molecular Sequence Data , Rats , Receptors, Bradykinin/metabolism , Species Specificity
2.
Eur J Pharmacol ; 266(3): 277-82, 1994 Feb 15.
Article in English | MEDLINE | ID: mdl-8174610

ABSTRACT

Kinin B1 receptors on rabbit aorta smooth muscle cells in culture were investigated. [3H]Des-Arg10-kallidin labeled a single site in cells at early passage with an equilibrium dissociation constant of 258 pM and a maximal binding density of approximately 680 sites/cell. Treatment of the same cells for 18 h with epidermal growth factor increased the binding density over 6-fold without affecting the ligand's affinity. At latter passages, the density of binding sites was found to increase and the growth factor had a much less pronounced effect. The rank order of potencies for agonist inhibition of binding (des-Arg10-kallidin > des-Arg9-BK = kallidin > bradykinin) was consistent with the specific labeling of a B1 receptor. Also, [3H]des-Arg10-kallidin binding was potently inhibited by the B1 receptor antagonist des-Arg9[Leu8]bradykinin but not by the B2 receptor antagonist Hoe 140. The agonists were found to stimulate phosphoinositide hydrolysis in the smooth muscle cells with an order of potencies that reflected their binding assay activities. Des-Arg9[Leu8] BK blocked the des-Arg10-kallidin response with a potency consistent with its known B1 receptor activity while Hoe 140 was inactive. These results demonstrate the presence of inducible B1 receptors on rabbit aorta smooth muscle cells in culture that couple to phospholipase C activation. These cells should be useful in future studies of the mechanisms and factors involved in the regulation of expression of the B1 receptor.


Subject(s)
Bradykinin/analogs & derivatives , Kallidin/analogs & derivatives , Muscle, Smooth, Vascular/metabolism , Receptors, Bradykinin/metabolism , Animals , Aorta/metabolism , Binding Sites , Binding, Competitive , Bradykinin/metabolism , Bradykinin/pharmacology , Cells, Cultured , Enzyme Activation/physiology , Hydrolysis , Kallidin/metabolism , Kallidin/pharmacology , Lysophospholipase/metabolism , Muscle, Smooth, Vascular/cytology , Phosphatidylinositols/metabolism , Rabbits , Receptors, Bradykinin/drug effects
3.
Mol Pharmacol ; 45(1): 1-8, 1994 Jan.
Article in English | MEDLINE | ID: mdl-8302267

ABSTRACT

The pharmacology of cloned B2 bradykinin receptors heterologously expressed in cell lines lacking any endogenous bradykinin receptors was analyzed. The possibility of B2 bradykinin receptor heterogeneity had been proposed on the basis of numerous studies in various tissue preparations. The results reported here permit a direct evaluation of some of these hypotheses by examining the pharmacological properties of cloned bradykinin receptors. A cloned human B2 bradykinin receptor was stably transfected into Chinese hamster ovary cells. The data suggest that in response to bradykinin (BK), the cloned receptor activates both phosphatidylinositol hydrolysis and arachidonic acid release by independent pathways. Thus, the activation of these two second messenger pathways does not require the existence of two B2 bradykinin receptor subtypes. A mouse gene encoding the B2 bradykinin receptor was isolated, and the coding region was expressed in COS-7 cells. This murine receptor exhibited the pharmacological properties of a "classical" B2 bradykinin receptor. A comparison of the pharmacological profiles of cloned human and murine homologs of the B2 bradykinin receptor indicates that both receptors bind agonists with similar properties. However, the two receptors differ dramatically in their affinity for some peptide antagonists. The mouse receptor has a 60- to 80-fold higher affinity for [D-Arg0Hyp3, Thi5,8,D-Phe7]BK and [D-Arg0,Hyp3,D-Phe7]BK than its human homolog. Thus, the species of a bradykinin receptor can have a significant effect on its pharmacology. The cloning, expression, and pharmacological comparison of human and mouse B2 bradykinin receptor genes indicate that some of the previous reports of B2 receptor subtypes can be explained by species differences in a single B2 bradykinin receptor gene.


Subject(s)
Receptors, Bradykinin/drug effects , Amino Acid Sequence , Animals , Base Sequence , Binding, Competitive , CHO Cells , Cell Line , Cloning, Molecular , Cricetinae , DNA, Complementary , Humans , Mice , Molecular Sequence Data , Receptors, Bradykinin/genetics , Receptors, Bradykinin/metabolism , Species Specificity
4.
Life Sci ; 53(25): 1879-86, 1993.
Article in English | MEDLINE | ID: mdl-8255148

ABSTRACT

A high affinity radioligand for bradykinin B2 receptors was prepared by coupling an activated ester of [125I]4-iodobenzoic acid to the amino terminus nitrogen of the potent B2 antagonist HOE 140. The ligand, [125I]para-iodophenyl HOE 140 ([125I]PIP HOE 140), bound to a homogeneous set of sites in guinea pig ileal membranes with an equilibrium dissociation constant of 15 pM and a maximal binding density of 193 fmole/mg protein. Competition studies with a number of BK-related peptides indicated that the ligand specifically labeled B2 receptors in the preparation. The results suggest that [125I]PIP HOE 140 will be a useful tool for future studies of B2 receptors.


Subject(s)
Bradykinin/analogs & derivatives , Ileum/metabolism , Receptors, Bradykinin/metabolism , Amino Acid Sequence , Animals , Binding, Competitive , Bradykinin/antagonists & inhibitors , Bradykinin/chemical synthesis , Bradykinin/metabolism , Bradykinin/pharmacology , Cell Membrane/metabolism , Guinea Pigs , Iodine Radioisotopes , Kinetics , Male , Molecular Sequence Data , Muscle, Smooth/metabolism , Radioligand Assay , Receptors, Bradykinin/drug effects , Receptors, Bradykinin/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...